BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Career Advice

  How to Continually Invest in Your Career

  Think of your career as a living, breathing thing. In order to keep it alive, you need to continually feed it so it can thrive. But how do you do that?

  August 21, 2019

   · 

  2 min read

   · 

  Laura Brothers
• Business

  NeuroVive Pharmaceutical AB Interim Report January - June 2019

  The US Food and Drug Administration, FDA, approves NeuroVive’s IND (Investigational New Drug) application, enabling clinical studies in the US with the company’s drug candidate NeuroSTAT.

  August 21, 2019

   · 

  3 min read
• Deals

  Hansa Biopharma to Participate in Three Upcoming Investor Conferences

  Hansa Biopharma has been invited to participate in three global biotech and healthcare conferences during September including Goldman Sachs’ Biotech Symposium in London, Morgan Stanley’s Global Healthcare conference in New York City and Bank of America Merrill Lynch Global Healthcare Conference in London

  August 21, 2019

   · 

  1 min read
• Drug Development

  BioInvent Will Conduct Phase l/lla Trial With BI-1206 in Combination With Pembrolizumab (Keytruda) in Solid Tumors

  BioInvent International AB announced that the earlier communicated phase l/lla clinical trial in solid cancer will be conducted with BI-1206, one of BioInvent’s proprietary anti-FcγRllB antibodies, in combination with pembrolizumab, a leading anti-PD1 antibody.

  August 21, 2019

   · 

  3 min read
• Business

  Tilray® Announces Agreement to Export First Shipment of Medical Cannabis From Portugal to Germany

  Tilray, Inc. announced it has entered into an agreement with Cannamedical Pharma GmbH through its wholly-owned subsidiary Tilray Portugal Unipessoal Lda., to export a wholesale shipment of $3.3 million worth of medical cannabis from Portugal to Germany.

  August 21, 2019

   · 

  5 min read
• Policy

  Largest Physician Quality Improvement Initiative in California History Yields Huge Health Benefit for Patients, $345 Million in Savings

  9,800 California providers work together to improve health for 5.9 million Californians, saving $6 for every $1 invested

  August 21, 2019

   · 

  5 min read
• Job Trends

  A Force for Change: DaVita Continues to Prioritize Environmental Sustainability

  DaVita Kidney Care, celebrated its 2019 sustainability milestones

  August 21, 2019

   · 

  4 min read
• Mallinckrodt to Present at Morgan Stanley 17th Annual Global Healthcare Conference

  Mallinckrodt Pharmaceuticals, a global biopharmaceutical company, will present on Tuesday, Sept. 10, 2019, at the Morgan Stanley 17th Annual Global Healthcare Conference at the Grand Hyatt, 109 E. 42nd St., New York.

  August 21, 2019

   · 

  2 min read
• Bio NC

  TransEnterix to Present at the Wells Fargo Securities Research, Economics & Strategy 2019 Healthcare Conference

  TransEnterix, Inc. announced that Todd M. Pope, President and Chief Executive Officer and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the Wells Fargo Securities Research, Economics & Strategy 2019 Healthcare Conference in Boston, MA.

  August 21, 2019

   · 

  1 min read
• Business

  Lussier Dale Parizeau is Pleased to Appoint its New President and Chief Operating Officer

  André Lussier, Chairman of the Board of Directors of Lussier Dale Parizeau, is pleased to appoint Michel Laurin as President and Chief Operating Officer of the company.

  August 21, 2019

   · 

  2 min read